The WOEST 2 registry: A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention

BACKGROUND: Patients on oral anticoagulants (OACs) undergoing percutaneous coronary intervention (PCI) also require aspirin and a P2Y12 inhibitor (triple therapy). However, triple therapy increases bleeding. The use of non-vitamin K antagonist oral anticoagulants (NOACs) and stronger P2Y12 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: de Veer, A. J. W. M., Bennaghmouch, N., Bor, W. L., Herrman, J. P. R., Vrolix, M., Meuwissen, M., Vandendriessche, T., Adriaenssens, T., de Bruyne, B., Magro, M., Dewilde, W. J. M, ten Berg, J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123099/
https://www.ncbi.nlm.nih.gov/pubmed/35230636
http://dx.doi.org/10.1007/s12471-022-01664-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123099/
https://www.ncbi.nlm.nih.gov/pubmed/35230636
http://dx.doi.org/10.1007/s12471-022-01664-0

Ejemplares similares